Previous 10 | Next 10 |
2024-04-11 12:24:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks can offer some of the most explosive, exciting opportunities on the market. That is, if you find the right one. Viking Therapeutics (NASDAQ: VKTX ) is the...
2024-03-27 08:24:20 ET More on premarket gainers & stock Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast gains as FDA backs regulatory plans fo...
2024-03-21 20:22:02 ET Journey Medical Corporation (DERM) Q4 2023 Earnings Conference Call March 21, 2024 04:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founder, President and CEO Joseph Benesch - Interim...
2024-03-21 16:04:13 ET More on Journey Medical Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment Journey Medical submits NDA for DFD-29 for rosacea Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data fo...
Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost savings in 2023, ahead of initial guidance of $...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
2024-03-20 17:35:53 ET More on Journey Medical Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment Journey Medical submits NDA for DFD-29 for rosacea Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data fo...
2024-03-20 17:35:09 ET Major earnings expected after the bell on Thursday include: NIKE ( NKE ) FedEx Corporation ( FDX ) Lululemon Athletica ( LULU ) Asensus Surgical ( ASXC ) AAR Corp. ( AIR ) Read the full article on Seeking Alpha F...
2024-03-18 09:17:32 ET More on Journey Medical Journey Medical submits NDA for DFD-29 for rosacea Journey Medical secures credit facility for up to $20M Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data for Journey Medical ...
SCOTTSDALE, Ariz., March 18, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (...
News, Short Squeeze, Breakout and More Instantly...
Journey Medical Corporation Company Name:
DERM Stock Symbol:
NASDAQ Market:
Journey Medical Corporation Website:
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or "the Company") (NASDAQ:DERM), a commercial...
SCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (...
New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a 7% increase from the $12.2 million reported in the...